Seongnam-si, South Korea

Wol-Young Kim



 

Average Co-Inventor Count = 4.5

ph-index = 2

Forward Citations = 5(Granted Patents)


Location History:

  • Seongnam-si, KR (2013 - 2017)
  • Gyeonggi-do, KR (2021)

Company Filing History:


Years Active: 2013-2021

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Wol-Young Kim: Innovator in Pharmaceutical Chemistry

Introduction

Wol-Young Kim is a notable inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 3 patents. His work focuses on developing novel compounds that have potential applications in treating serious health conditions.

Latest Patents

Among his latest patents is a phenylpyridine derivative and pharmaceutical composition comprising the same. This innovative compound is represented by Chemical Formula 1 and is designed for the prevention or treatment of autoimmune diseases or cancers. Another significant patent is a process for preparing an ertapenem-containing lyophilized formulation. This process utilizes hydroxypropyl β-cyclodextrin as both a cryoprotective agent and a stabilizing agent, showcasing his expertise in formulation chemistry.

Career Highlights

Wol-Young Kim is currently associated with Daewoong Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work has been instrumental in creating effective pharmaceutical solutions that address critical health issues.

Collaborations

He has collaborated with notable colleagues, including Bong-Yong Lee and Hee-kyoon Yoon, who contribute to his innovative projects and research endeavors.

Conclusion

Wol-Young Kim's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the field. His work not only advances scientific knowledge but also has the potential to improve patient outcomes in the treatment of serious diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…